Wein Matthew
SEC CIK 2009713 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MGX | Metagenomi Therapeutics, Inc. | See Remarks | 126.1K | — | $4,711 | 11 | 2024-04-01 | 2026-09-08 |
Most active insiders at MGX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Reid Laurence | Dir | $23.4K | — |
| 2 | Irish Jian | See Remarks, Dir | — | $12.7K |
| 3 | Wapnick Pamela | CFO | — | $11.3K |
| 4 | Thomas Brian C. | Dir | — | $6,779 |
| 5 | Wein Matthew | See Remarks | — | $2,263 |
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-10 15:47 | 2026-09-08 | MGX | Metagenomi Therapeutics, Inc. | Wein Matthew | See Remarks | S - Sale | $1.16 | -358 | 126.1K | -0.3% | -$414.71 | |
| 2026-06-10 11:19 | 2026-06-05 | MGX | Metagenomi Therapeutics, Inc. | Wein Matthew | See Remarks | S - Sale | $1.30 | -558 | 126.5K | -0.4% | -$724.84 | |
| D | 2026-04-03 14:00 | 2026-04-01 | MGX | Metagenomi Therapeutics, Inc. | Wein Matthew | See Remarks | A - Grant | $0.00 | +11.0K | 125.5K | +10% | $0 |
| 2026-03-09 | 2026-03-05 | MGX | Metagenomi Therapeutics, Inc. | Wein Matthew | See Remarks | S - Sale | $1.60 | -482 | 114.5K | -0.4% | -$771.20 | |
| 2025-12-08 | 2025-12-05 | MGX | Metagenomi Therapeutics, Inc. | Wein Matthew | See Remarks | S - Sale | $1.77 | -199 | 115.0K | -0.2% | -$352.23 | |
| 2025-12-01 | 2025-09-05 | MGX | Metagenomi Therapeutics, Inc. | Wein Matthew | See Remarks | S - Sale | $1.81 | -199 | 19.2K | -1% | -$360.19 | |
| 2025-12-01 | 2025-12-01 | MGX | Metagenomi Therapeutics, Inc. | Wein Matthew | See Remarks | A - Grant | $1.60 | +96.0K | 115.2K | +499% | +$153.6K | |
| 2025-06-09 | 2025-06-06 | MGX | Metagenomi Therapeutics, Inc. | Wein Matthew | See Remarks | S - Sale | $1.75 | -199 | 16.7K | -1% | -$348.25 | |
| DM | 2025-04-03 | 2025-04-01 | MGX | Metagenomi Therapeutics, Inc. | Wein Matthew | See Remarks | A - Grant | $0.00 | +7,425 | 13.1K | +130% | $0 |
| 2025-03-07 | 2025-03-05 | MGX | Metagenomi Therapeutics, Inc. | Wein Matthew | See Remarks | S - Sale | $1.87 | -930 | 9,467 | -9% | -$1,739 | |
| D | 2024-04-03 | 2024-04-01 | MGX | Metagenomi Therapeutics, Inc. | Wein Matthew | See Remarks | A - Grant | $0.00 | +10.4K | 10.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations